Volume | 0.00 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Predictive Technology Group Inc (CE) | PRED | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0003 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0.00 | - | 0.0001 - 0.0201 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.0003 | USD |
Predictive Technology Group Inc (CE) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 95.00k | 316.67M | 35.64M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Predictive Technology (CE) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRED Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 10,027 | 0.00 | 0.0% |
1 Month | 0.0001 | 0.0003 | 0.0001 | 0.0001169 | 33,906 | 0.0002 | 200.0% |
3 Months | 0.0002 | 0.0003 | 0.0001 | 0.0001831 | 60,936 | 0.0001 | 50.0% |
6 Months | 0.0003 | 0.0003 | 0.0001 | 0.0002031 | 50,828 | 0.00 | 0.0% |
1 Year | 0.0003 | 0.0201 | 0.0001 | 0.0002576 | 70,333 | 0.00 | 0.0% |
3 Years | 0.11 | 0.67 | 0.0001 | 0.1333363 | 205,082 | -0.1097 | -99.73% |
5 Years | 1.05 | 6.91 | 0.0001 | 0.9974073 | 300,051 | -1.05 | -99.97% |
Predictive Technology (CE) Description
Predictive Technology Group, Inc. (Stock Symbol: PRED), a Salt Lake City, UT therapeutics and life sciences company, is a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through unique novel gene-based diagnostics, biotechnology treatments and companion therapeutics. Through its' wholly-owned subsidiaries, Predictive Therapeutics and Predictive Biotech, the company focuses on four main clinical categories: Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. In addition to Predictive Biotech's efforts to advance regenerative medicine, Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis via appropriate early-stage diagnosis and subsequent treatment. |